Finance

Lists
Why is 300255 up 4.12%?
Dive Deeper
300255:SHE
Hebei Changshan Biochemical Pharm Co Ltd
CNÂ¥19.98
+4.12%
(+0.79) 1D
Nov 4, 3:04:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300255...
Open
CNÂ¥19.20
High
CNÂ¥20.07
Low
CNÂ¥19.08
Mkt. cap
17.64B
Avg. vol.
18.83M
Volume
24.85M
52-wk high
CNÂ¥70.00
52-wk low
CNÂ¥18.36
EPS
-CNÂ¥0.38
Shares outstanding
919.06M
No. of employees
1K
Open
CNÂ¥19.20
High
CNÂ¥20.07
Low
CNÂ¥19.08
Mkt. cap
17.64B
Avg. vol.
18.83M
Volume
24.85M
52-wk high
CNÂ¥70.00
52-wk low
CNÂ¥18.36
EPS
-CNÂ¥0.38
Shares outstanding
919.06M
No. of employees
1K
News stories
From web sources and news partners
About Hebei Changshan Biochemical Pharm Co Ltd
CEO-
Employees1.19K
Founded1992
Headquarters-
SectorPharmaceutical industry
Industry-
Websitehbcsbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
193.91M
256.10M
219.72M
260.54M
Cost of goods sold
281.46M
193.11M
179.86M
197.91M
Cost of revenue
281.46M
193.11M
179.86M
197.91M
Research and development expenses
9.51M
7.23M
8.69M
8.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.72M
30.76M
30.39M
38.54M
Operating expense
143.40M
38.30M
42.40M
43.77M
Total operating expenses
424.86M
231.40M
222.26M
241.68M
Operating income
-230.95M
24.70M
-2.54M
18.86M
Other non operating income
-28.67M
-3.36M
3.51M
-7.32M
EBT including unusual items
-301.55M
5.20M
-24.37M
-19.56M
EBT excluding unusual items
-282.26M
-355.86K
-25.59M
-16.07M
Income tax expense
8.93M
1.82M
761.85K
4.84M
Effective tax rate
-2.96%
35.03%
-3.13%
-24.72%
Other operating expenses
5.43M
2.02M
759.88K
-1.13M
Net income
-313.08M
5.87M
-22.63M
-21.13M
Net profit margin
-161.45%
2.29%
-10.30%
-8.11%
Earnings per share
-
-
-
-
Interest and investment income
531.86K
117.28K
28.28K
428.47K
Interest expense
-28.42M
-21.82M
-23.56M
-31.07M
Net interest expenses
-27.89M
-21.70M
-23.53M
-30.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-214.14M
41.52M
14.11M
35.68M
Gain or loss from assets sale
228.40K
-
6.30K
-6.30K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps